Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Proteomics Clin Appl. 2018 Dec 19;13(4):e1800129. doi: 10.1002/prca.201800129

Figure 3. Assessment of Anti-carbohydrate Antibodies in Mechanical Valve and GFBP Valve Patients.

Figure 3.

(A) Representative western blot, a: ladder b: native BP protein probed with mechanical valve patient serum c: de-glycosylated BP protein probed with mechanical valve patient serum d: native BP protein probed with GFBP valve patient serum e: de-glycosylated BP protein probed with GFBP valve patient serum. (B) Densitometry analysis of western blots. (C) alpha-gal ELISA for antibodies against the alpha-gal epitope in GFBP valve, Mechanical valve and healthy control patients. All groups have n=6 biological replicates (* p < 0.05).